Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs GH✓SelectedUSD · GHMRNA vs GH performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs GH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+152.4%
GH return
+523.2%
Excess return
-370.8%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGHExcessAlpha
1D+1.3%+0.3%+1.0%+1.2%
7D-13.8%-6.0%-7.9%-12.2%
30D-17.7%-10.5%-7.2%-14.9%
3M+14.3%-10.9%+25.2%+18.3%
6M+336.0%+48.3%+287.7%+299.6%
YTD+575.9%+42.5%+533.4%+520.8%
1Y+724.4%+46.2%+678.1%+651.2%
All+152.4%+523.2%-370.8%+78.4%

Cumulative growth

Daily Returns

Daily percentage return beside GH.

Daily Out/Under-Performance

Portfolio return minus GH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling